Skip to main content
Premium Trial:

Request an Annual Quote

Dx Focus: Abbott mPlus for RealTime m2000 System

Premium

Abbott this week introduced the mPlus, a new capability for its RealTime m2000 molecular diagnostics system.

The mPlus capability makes it possible for laboratories of any size to perform molecular diagnostic tests for infectious disease detection and therapy monitoring. Specifically, it will give laboratories the ability to process samples when they are ready rather than holding them for larger batch runs, thus providing faster results to patients. mPlus will also optimize reagent use, reduce laboratory cost of operations, and offer a new automatic inventory feature to improve system and ease of use, Abbott said.

mPlus capability is currently available for Abbott's RealTime HIV, HCV, HBV, CT/NG, and CT assays outside the US and for the RealTime CT/NG assay within the US.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.